Moreover, in AR-CLSD forms, the variants in SEC23A affect the early exons of the gene (except for patient 5 who is a compound heterozygous [18]) while, in AD-CLSD forms, they are present in the last exons of the gene. The gene discussed is SEC23A; the disease is Alzheimer disease.